Is digoxin contraindicated in a patient with hypothyroidism?

Digoxin is NOT contraindicated in patients with hypothyroidism, but requires careful dose adjustment and monitoring

Digoxin can and should be used in hypothyroid patients when clinically indicated, but hypothyroidism significantly increases the risk of digoxin toxicity even at therapeutic serum levels, necessitating lower doses and closer monitoring. 1, 2

Key Clinical Considerations

Why Hypothyroidism Increases Toxicity Risk

Hypothyroidism creates a "perfect storm" for digoxin toxicity through multiple mechanisms:

• Reduced digoxin requirements: Hypothyroid patients need less digoxin to achieve therapeutic effect 2
• Decreased renal clearance: Glomerular filtration rate is reduced in hypothyroidism, leading to elevated serum digoxin levels 3, 4
• Increased myocardial sensitivity: The hypothyroid myocardium is more sensitive to digoxin's effects, meaning toxicity can occur at lower serum concentrations (even below 2.0 ng/mL) 1, 5
• Altered P-glycoprotein function: Hypothyroidism decreases ABCB1/P-glycoprotein expression and function, reducing digoxin clearance by 26% 6

Practical Management Algorithm

For hypothyroid patients requiring digoxin:

1. Start with reduced doses: Use 0.125 mg daily or every other day initially (similar to elderly or renally impaired patients) 1

2. Target lower therapeutic levels: Aim for serum digoxin concentrations of 0.5-0.9 ng/mL (lower end of therapeutic range) 1

3. Monitor closely for toxicity signs:

   • Cardiac: bradycardia, AV block, ventricular arrhythmias 1, 7
   • GI: nausea, anorexia, vomiting 1
   • Neurologic: visual disturbances, confusion 1

4. Check electrolytes frequently: Maintain potassium >4.0 mEq/L and magnesium ≥2.0 mEq/L, as deficiencies potentiate toxicity 1, 2

5. Reassess when thyroid status changes: If levothyroxine is initiated or adjusted, digoxin requirements will increase as thyroid function normalizes 2, 8, 6

Critical Pitfall to Avoid

The most dangerous scenario occurs when treating hypothyroidism in a patient already on digoxin. As thyroid hormone replacement normalizes thyroid function, digoxin clearance increases and myocardial sensitivity decreases. The FDA label explicitly warns: "Thyroid administration to a digitalized, hypothyroid patient may increase the dose requirement of digoxin" 2. This means a previously adequate digoxin dose may become subtherapeutic, potentially leading to loss of rate control in atrial fibrillation or worsening heart failure symptoms.

Evidence Quality Note

The 2013 ACC/AHA Heart Failure Guidelines 1 and 2018 AHA/ACC/HRS Arrhythmia Guidelines 7 consistently identify hypothyroidism as a potentiating factor for digoxin toxicity. The FDA drug label 2 provides the same warning. Research evidence from pharmacokinetic studies 3, 9, 4, 6 demonstrates measurable alterations in digoxin clearance and distribution in hypothyroid states, with normalization upon treatment.

Bottom line: Use digoxin in hypothyroid patients when indicated, but start low (0.125 mg or less), monitor closely, and anticipate the need for dose increases if thyroid replacement therapy is initiated.